Lunit
Medical AI company specializing in cancer detection and precision oncology through AI analysis of radiology images and pathology slides.
About
Lunit develops FDA-cleared and CE-marked AI software for cancer screening and treatment guidance. On the screening side, its algorithms analyze mammograms and chest X-rays to flag potential lesions and assess breast density. For precision oncology, Lunit's pathology AI quantifies biomarkers such as PD-L1 and HER2, maps the tumor microenvironment, and predicts genotype from tissue images, helping oncologists and pharmaceutical researchers select the most appropriate therapies. The platform is deployed at healthcare facilities and used by biopharma partners to support clinical trial development. Pricing is available through direct contact with Lunit's commercial team.